Comparison of the effectiveness, safety, and costs of anti-Parkinson drugs: A multiple-center retrospective study.
CNS Neurosci Ther
; 30(4): e14531, 2024 04.
Article
in En
| MEDLINE
| ID: mdl-37983933
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Parkinson Disease
/
Levodopa
Limits:
Humans
Language:
En
Journal:
CNS Neurosci Ther
Journal subject:
NEUROLOGIA
/
TERAPEUTICA
Year:
2024
Document type:
Article
Affiliation country: